Cargando…
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
BACKGROUND: Vaccination against seasonal influenza strains is recommended for “high risk” patient groups such as infants, elderly and those with respiratory or circulatory diseases. However, efficacy of the trivalent influenza vaccine (TIV) is poor in many cases and in the event of an influenza pand...
Autores principales: | Heath, M. D, Swan, N. J., Marriott, A. C., Silman, N. J., Hallis, B., Prevosto, C., Gooch, K. E., Skinner, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369220/ https://www.ncbi.nlm.nih.gov/pubmed/28347293 http://dx.doi.org/10.1186/s12879-017-2329-5 |
Ejemplares similares
-
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT(®))
por: Heath, Matthew D., et al.
Publicado: (2020) -
Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017) -
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy()
por: Justicia, José L., et al.
Publicado: (2021) -
MicroCrystalline Tyrosine-adsorbed immunotherapy
por: Al Saleh, Helal, et al.
Publicado: (2022) -
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling
por: Leuthard, Deborah S., et al.
Publicado: (2018)